Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

OUABAIN CRS (150 MG)

OUABAIN CRS (150 MG)

11018-89-6

DISCOVER
OXAZEPAM CRS - * PSY (50 MG)

OXAZEPAM CRS - * PSY (50 MG)

604-75-1

DISCOVER
OXFENDAZOLE CRS (50 MG)

OXFENDAZOLE CRS (50 MG)

53716-50-0

DISCOVER
Oxytetracycline HCl

Oxytetracycline HCl

2058-46-0

DISCOVER
OXOLINIC ACID CRS (50 MG)

OXOLINIC ACID CRS (50 MG)

14698-29-4

DISCOVER
OXOLINIC ACID IMPURITY A CRS (20 MG)

OXOLINIC ACID IMPURITY A CRS (20 MG)

NA

DISCOVER
OXOLINIC ACID IMPURITY B CRS (20 MG)

OXOLINIC ACID IMPURITY B CRS (20 MG)

NA

DISCOVER
OXPRENOLOL HYDROCHLORIDE CRS (50 MG)

OXPRENOLOL HYDROCHLORIDE CRS (50 MG)

6452-73-9

DISCOVER
Oleate de sodium

Oleate de sodium

143-19-1

DISCOVER
OXYBUPROCAINE HYDROCHLORIDE CRS (100 MG)

OXYBUPROCAINE HYDROCHLORIDE CRS (100 MG)

5987-82-6

DISCOVER
OXYBUTYNIN HYDROCHLORIDE CRS (50 MG)

OXYBUTYNIN HYDROCHLORIDE CRS (50 MG)

1508-65-2

DISCOVER
OXYBUTYNIN IMPURITY A CRS (20MG)

OXYBUTYNIN IMPURITY A CRS (20MG)

NA

DISCOVER